Advanced company searchLink opens in new window

ASTEX THERAPEUTICS LIMITED

Company number 03751674

Filter by category

Filter by category


Confirmation statement filters, selecting an input will reload the page.
Confirmation statement filters, selecting an input will reload the page.

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
30 Jul 2026 CS01 Confirmation statement made on 2 May 2026 with no updates
28 Jul 2026 AP01 Appointment of Mr Yoshihisa Yamada as a director on 1 April 2026
28 Jul 2026 AP01 Appointment of Mr John Edward Kraus as a director on 1 April 2026
26 Jul 2026 TM01 Termination of appointment of Tsuyoshi Nakamura as a director on 31 March 2026
26 Jul 2026 TM01 Termination of appointment of Robert Dwyer Mcquade as a director on 31 March 2026
25 Feb 2026 AA Full accounts made up to 31 December 2025
17 Nov 2025 AP01 Appointment of Mr Tsuyoshi Nakamura as a director on 1 October 2025
13 Nov 2025 AP01 Appointment of Dr Michelle Ann Jones as a director on 1 October 2025
13 Nov 2025 TM01 Termination of appointment of Harren Jhoti as a director on 30 September 2025
13 Nov 2025 TM01 Termination of appointment of Toshiki Sudo as a director on 20 September 2025
02 May 2025 CS01 Confirmation statement made on 2 May 2025 with no updates
11 Apr 2025 AP01 Appointment of Dr Takayuki Shiratsuchi as a director on 1 March 2025
11 Apr 2025 AP01 Appointment of Dr Roberto Celeste Ercole Solari as a director on 1 March 2025
11 Apr 2025 AP01 Appointment of Dr Brian Jude Gerard Pereira as a director on 1 March 2025
10 Apr 2025 TM01 Termination of appointment of Thomas Leon Blundell as a director on 1 March 2025
10 Apr 2025 TM01 Termination of appointment of Yasuhisa Kurogi as a director on 1 March 2025
07 Mar 2025 AA Full accounts made up to 31 December 2024
14 May 2024 CS01 Confirmation statement made on 3 May 2024 with no updates
09 Apr 2024 AA Full accounts made up to 31 December 2023
12 Mar 2024 AP01 Appointment of Dr Yasuhisa Kurogi as a director on 1 March 2024
08 Mar 2024 TM01 Termination of appointment of Michael Edward Gehrke as a director on 1 March 2024
24 May 2023 AP01 Appointment of Michael Edward Gehrke as a director on 1 March 2023
17 May 2023 CS01 Confirmation statement made on 3 May 2023 with no updates
14 Mar 2023 AA Full accounts made up to 31 December 2022
03 May 2022 CS01 Confirmation statement made on 3 May 2022 with updates